Together our data suggest that CXCL16 and CXCR6 may contribute to tumor progression directly through effects on cancer cell growth, and indirectly, by enhancing leukocyte recruitment and proliferation and the interactions between leukocytes and pre-malignant/malignant cells. The gene discussed is CXCL16; the disease is neoplasm.